Monte Rosa Therapeutics, Inc. - GLUE

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$2.268B

QoQ value delta ($000)

+$833.2M (+58.06%)

Implied price effect (QoQ)

+46.74%

Total shares

93,972,749

QoQ shares delta

+6,735,403 (+7.72%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 194 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
PRICE T ROWE ASSOCIATES INC /MD/	214,442	8,861,171	0.02%
NEA Management Company, LLC	186,153	7,692,298	11.72%
BlackRock, Inc.	165,602	6,843,087	0.0%
TCG Crossover Management, LLC	111,856	4,622,151	2.69%
Vestal Point Capital, LP	111,320	4,600,000	2.6%
BVF INC/IL	107,953	4,460,886	2.76%
BAKER BROS. ADVISORS LP	105,166	4,345,736	0.53%
STATE STREET CORP	90,300	3,731,416	0.0%
MONTANOVA CAPITAL, LLC	85,898	3,549,539	1.57%
VANGUARD CAPITAL MANAGEMENT LLC	82,592	3,412,927	0.0%
Versant Venture Management, LLC	76,974	3,180,780	47.34%
BRAIDWELL LP	59,327	2,451,562	2.19%
GEODE CAPITAL MANAGEMENT, LLC	45,121	1,864,113	0.0%
AMERICAN CENTURY COMPANIES INC	39,272	1,622,846	0.02%
MARSHALL WACE, LLP	38,565	1,593,600	0.03%
Aisling Capital Management LP	37,647	1,555,664	7.98%
Bellevue Group AG	28,798	1,190,000	0.61%
DIMENSIONAL FUND ADVISORS LP	28,493	1,177,488	0.01%
MPM BioImpact LLC	28,098	1,161,081	1.71%
SILVERARC CAPITAL MANAGEMENT, LLC	26,820	1,108,295	2.79%
Jupiter Topco LLC	25,965	1,072,494	0.01%
Frazier Life Sciences Management, L.P.	24,200	1,000,000	0.53%
GOLDMAN SACHS GROUP INC	24,157	998,253	0.0%
Woodline Partners LP	23,301	962,884	0.07%
FMR LLC	22,612	934,414	0.0%